LIFESTYLE

Nearly One in Five Babies in South Korea Born Through Government-Backed Infertility Treatment in 2025

The Ministry of Health and Welfare announced on Thursday that a total of 48,981 babies were born in 2025 through the infertility treatment support program. This figure represents 19.2% of the total 254,457 births, meaning that approximately one in fi

Seoul Asan Team Performs Asia-Pacific’s First Robotic Supermicrosurgery Connecting Submillimeter Vessels

South Korean researchers have successfully connected blood vessels thinner than a human hair using a supermicrosurgery robot for the first time in the Asia-Pacific region.Seoul Asan Medical Center said Thursday that a plastic surgery team led by Prof

ST Pharm Expands Global CDMO Outreach at TIDES USA and ASGCT 2026

ST Pharm announced on Thursday that it participated in both TIDES USA 2026 and the world's largest American Society of Gene & Cell Therapy (ASGCT) 2026 events. These conferences were held simultaneously at the Hynes Convention Center in Boston from M

Yuhan to Receive $30 Million Milestone From European Launch of Lazertinib Combination Therapy

Yuhan Corporation announced on Thursday that it will receive a 30 million USD milestone payment for the European commercialization of Lazertinib, its non-small cell lung cancer treatment licensed to Janssen Biotech. This payment is part of a series o

South Korean Team Develops Non-Invasive Device for Early Cardiovascular Risk Screening

A team of South Korean researchers has developed a groundbreaking non-invasive medical device that can predict cardiovascular health by analyzing pulse waves from the arms, legs, and neck.Gangnam Severance Hospital announced on Thursday that Dr. Lee

Samsung Epis Holdings Earns MSCI AA Rating in First Global ESG Assessment

Samsung Epis Holdings, a biotech holding company, announced on Thursday that it has achieved an AA rating in the Environmental, Social and Governance (ESG) evaluation conducted by Morgan Stanley Capital International (MSCI), a global investment infor

U.S., Japan and China Advance Stem Cell Commercialization While Korea Works to Close Gaps

The global stem cell therapy market is experiencing rapid growth. According to authorities like the Korea Health Industry Development Institute, the market is projected to expand from approximately 13.78 billion USD in 2019 to around 23.96 billion US

MetaVia to Present DA-1726 Phase 1 Obesity Trial Data at EASL Congress 2026

Dong-A ST announced on Tuesday that its affiliate Meta via will present the latest clinical abstract (LBA) for DA-1726, a GLP-1 and glucagon dual-action obesity treatment, at the European Association for the Study of the Liver (EASL) annual congress,

South Korea Unveils New Blood Management Plan to Stabilize Supply Amid Demographic Shift

The government has initiated measures to ensure blood supply stability and promote a culture of blood donation, as participation from the key donor demographic of 10 to 29-year-olds declines due to low birth rates and an aging population. Plans inclu

The 2026 World Cup Could Bring More Than Soccer Fever, Korean Officials Warn

Korea Disease Control and Prevention Agency said Thursday it will provide infectious disease and heat illness prevention guidelines for South Korean athletes and travelers attending the 2026 FIFA World Cup.The tournament will be held across 16 cities